Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Collegium Pharmaceutical (COLL) Net Margin: 2014-2024

Historic Net Margin for Collegium Pharmaceutical (COLL) over the last 11 years, with Dec 2024 value amounting to 6.71%.

  • Collegium Pharmaceutical's Net Margin rose 919.00% to 15.05% in Q3 2025 from the same period last year, while for Sep 2025 it was 7.72%, marking a year-over-year decrease of 706.00%. This contributed to the annual value of 6.71% for FY2024, which is 141.00% down from last year.
  • Collegium Pharmaceutical's Net Margin amounted to 6.71% in FY2024, which was down 17.32% from 8.12% recorded in FY2023.
  • Collegium Pharmaceutical's Net Margin's 5-year high stood at 25.83% during FY2021, with a 5-year trough of -7.23% in FY2022.
  • Its 3-year average for Net Margin is 2.53%, with a median of 6.71% in 2024.
  • Per our database at Business Quant, Collegium Pharmaceutical's Net Margin soared by 1,720bps in 2021 and then plummeted by 3,306bps in 2022.
  • Yearly analysis of 5 years shows Collegium Pharmaceutical's Net Margin stood at 8.63% in 2020, then spiked by 1,720bps to 25.83% in 2021, then tumbled by 3,306bps to -7.23% in 2022, then skyrocketed by 1,535bps to 8.12% in 2023, then crashed by 141bps to 6.71% in 2024.